BiotechTube
Home/Xilio Therapeutics/Uli Bialucha
UB

Uli Bialucha

Chief Scientific Officer

Xilio Therapeutics

Therapeutic Areas

Oncology

Xilio Therapeutics Pipeline

DrugIndicationPhase
XTX101Advanced solid tumorsPhase 1
XTX202Advanced solid tumorsPhase 1

Leadership Team at Xilio Therapeutics

RR
René Russo
President, Chief Executive Officer and Board Member
SC
Scott Coleman
Chief Development Officer
CF
Chris Frankenfield
Chief Financial and Operating Officer
View full Xilio Therapeutics profile